Overview
Spondylocarpotarsal synostosis syndrome (SCT syndrome), also known as spondylocarpotarsal synostosis or congenital scoliosis with unilateral unsegmented bar, is a rare skeletal disorder characterized by the fusion (synostosis) of the vertebrae (spondylo-), carpal (wrist), and tarsal (ankle) bones. The condition primarily affects the skeletal system, leading to progressive vertebral fusions that result in a short trunk and disproportionate short stature. Vertebral block fusions, particularly involving the thoracic and lumbar spine, are a hallmark feature and can produce a characteristic unilateral unsegmented bar appearance on imaging. Additional skeletal findings include lordosis, scoliosis, and fusions of the carpal and tarsal bones. Affected individuals may also exhibit facial dysmorphism, including a broad nasal bridge and a round face, as well as dental anomalies and mild hearing loss in some cases. The condition is caused by biallelic pathogenic variants in the FLNB gene (filamin B), which encodes a cytoskeletal protein important for vertebral segmentation and skeletal development. The FLNB gene is also associated with other skeletal dysplasias, including Larsen syndrome and atelosteogenesis types I and III, though those conditions follow different inheritance patterns. Spondylocarpotarsal synostosis syndrome follows an autosomal recessive inheritance pattern. Onset is typically recognized in childhood, often when short stature or spinal abnormalities become clinically apparent, though vertebral fusions may be present from birth. There is currently no cure for spondylocarpotarsal synostosis syndrome. Management is supportive and multidisciplinary, focusing on orthopedic monitoring and intervention for progressive spinal deformities, which may include bracing or surgical correction in severe cases. Respiratory function should be monitored, as restrictive lung disease can develop secondary to thoracic vertebral fusions. Hearing assessments and dental evaluations are also recommended. Genetic counseling is important for affected families to understand recurrence risks.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Spondylocarpotarsal synostosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Spondylocarpotarsal synostosis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Spondylocarpotarsal synostosis.
Community
No community posts yet. Be the first to share your experience with Spondylocarpotarsal synostosis.
Start the conversation →Latest news about Spondylocarpotarsal synostosis
No recent news articles for Spondylocarpotarsal synostosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Spondylocarpotarsal synostosis
What is Spondylocarpotarsal synostosis?
Spondylocarpotarsal synostosis syndrome (SCT syndrome), also known as spondylocarpotarsal synostosis or congenital scoliosis with unilateral unsegmented bar, is a rare skeletal disorder characterized by the fusion (synostosis) of the vertebrae (spondylo-), carpal (wrist), and tarsal (ankle) bones. The condition primarily affects the skeletal system, leading to progressive vertebral fusions that result in a short trunk and disproportionate short stature. Vertebral block fusions, particularly involving the thoracic and lumbar spine, are a hallmark feature and can produce a characteristic unilate
How is Spondylocarpotarsal synostosis inherited?
Spondylocarpotarsal synostosis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Spondylocarpotarsal synostosis typically begin?
Typical onset of Spondylocarpotarsal synostosis is childhood. Age of onset can vary across affected individuals.
Which specialists treat Spondylocarpotarsal synostosis?
15 specialists and care centers treating Spondylocarpotarsal synostosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.